Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. Founded by Hossein Ghanbari, Sensei Biotherapeutics is backed by investors that include Apeiron Investment Group, Presight Capital, Catalio Capital Management, Cambrian Biopharma, and Pura Vida Investments and is headquartered in Gaithersburg.